Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery.

BACKGROUND Despite the routine use of prophylactic systemic antibiotics, surgical-site infection continues to be associated with significant morbidity and cost after colorectal surgery. The gentamicin-collagen sponge, an implantable topical antibiotic agent, is approved for surgical implantation in 54 countries. Since 1985, more than 1 million patients have been treated with the sponges. METHODS In a phase 3 trial, we randomly assigned 602 patients undergoing open or laparoscopically assisted colorectal surgery at 39 U.S. sites to undergo either the insertion of two gentamicin-collagen sponges above the fascia at the time of surgical closure (the sponge group) or no intervention (the control group). All patients received standard care, including prophylactic systemic antibiotics. The primary end point was surgical-site infection occurring within 60 days after surgery, as adjudicated by a clinical-events classification committee that was unaware of the study-group assignments. RESULTS The incidence of surgical-site infection was higher in the sponge group (90 of 300 patients [30.0%]) than in the control group (63 of 302 patients [20.9%], P=0.01). Superficial surgical-site infection occurred in 20.3% of patients in the sponge group and 13.6% of patients in the control group (P=0.03), and deep surgical-site infection in 8.3% and 6.0% (P=0.26), respectively. Patients in the sponge group were more likely to visit an emergency room or surgeon's office owing to a wound-related sign or symptom (19.7%, vs. 11.0% in the control group; P=0.004) and to be rehospitalized for surgical-site infection (7.0% vs. 4.3%, P=0.15). The frequency of adverse events did not differ significantly between the two groups. CONCLUSIONS Our large, multicenter trial shows that the gentamicin-collagen sponge is not effective at preventing surgical-site infection in patients who undergo colorectal surgery; paradoxically, it appears to result in significantly more surgical-site infections. (Funded by Innocoll Technologies; ClinicalTrials.gov number, NCT00600925.)

[1]  Charles B Cairns,et al.  Ethical and scientific implications of the globalization of clinical research. , 2009, The New England journal of medicine.

[2]  R. Bellomo,et al.  Why we should be wary of single-center trials , 2009, Critical care medicine.

[3]  L. Jørgensen,et al.  Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. , 2009, JAMA.

[4]  K. Itani,et al.  Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. , 2006, The New England journal of medicine.

[5]  S. Heard,et al.  Surgical site infection following bowel surgery: a retrospective analysis of 1446 patients. , 2006, Archives of surgery.

[6]  Vincent H. Tam,et al.  Comparative Pharmacodynamics of Gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa , 2006, Antimicrobial Agents and Chemotherapy.

[7]  D. Sessler,et al.  Antenatal Betamethasone and Incidence of Neonatal Respiratory Distress After Elective Caesarean Section: Pragmatic Randomized Trial , 2005, JAMA.

[8]  D. Sessler,et al.  Nitrous oxide and risk of surgical wound infection: a randomised trial , 2005, The Lancet.

[9]  D. Bratzler,et al.  Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. , 2005, American journal of surgery.

[10]  M. Nowacki,et al.  Prospective, randomized trial examining the role of gentamycin-containing collagen sponge in the reduction of postoperative morbidity in rectal cancer patients: early results and surprising outcome at 3-year follow-up , 2005, International Journal of Colorectal Disease.

[11]  B. Reeves,et al.  Surgical wound infection as a performance indicator: agreement of common definitions of wound infection in 4773 patients , 2004, BMJ : British Medical Journal.

[12]  R. Sawyer,et al.  Wound Infection After Elective Colorectal Resection , 2004, Annals of surgery.

[13]  C. Lien,et al.  Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. , 2004, JAMA.

[14]  W. Friess,et al.  Collagen as a carrier for on-site delivery of antibacterial drugs. , 2003, Advanced drug delivery reviews.

[15]  B. Söderquist,et al.  Antibiotic Concentrations in Serum and Wound Fluid after Local Gentamicin or Intravenous Dicloxacillin Prophylaxis in Cardiac Surgery , 2003, Scandinavian journal of infectious diseases.

[16]  O. Akca,et al.  Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. , 2000, The New England journal of medicine.

[17]  W E Wilkinson,et al.  The Impact of Surgical-Site Infections in the 1990s: Attributable Mortality, Excess Length of Hospitalization, And Extra Costs , 1999, Infection Control & Hospital Epidemiology.

[18]  G. Gómez,et al.  Effectiveness of Collagen–Gentamicin Implant for Treatment of “Dirty” Abdominal Wounds , 1999, World Journal of Surgery.

[19]  A. Kurz,et al.  Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. , 1996, The New England journal of medicine.

[20]  W J Martone,et al.  Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.

[21]  M. Kelsey,et al.  The use of the wound scoring method 'ASEPSIS' in postoperative wound surveillance. , 1990, The Journal of hospital infection.

[22]  R. Haley,et al.  Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. , 1985, American journal of epidemiology.

[23]  K. Bland.  Antimicrobial Prophylaxis for Surgery: An Advisory Statement From the National Surgical Infection Prevention Project , 2006 .

[24]  Aniel,et al.  PERIOPERATIVE NORMOTHERMIA TO REDUCE THE INCIDENCE OF SURGICAL-WOUND INFECTION AND SHORTEN HOSPITALIZATION , 2000 .

[25]  H. Rutten,et al.  Prevention of wound infection in elective colorectal surgery by local application of a gentamicin-containing collagen sponge. , 1997, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.